シーケンシング市場規模、シェア、動向分析レポート：製品・サービス別、用途別、ワークフロー別、最終用途別、地域別、セグメント別予測、2024年～2030年

シーケンシング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のシーケンシング市場規模は2024年から2030年にかけてCAGR 22.2%で成長し、2030年には624億8,000万米ドルに達すると予測されています。

政府や民間組織によるゲノム研究開発への投資の増加や、個別化医療や精密治療への需要の高まりが、これらの技術の採用増加につながり、市場をさらに押し上げると予測されています。例えば、2022年12月、英国政府は国民保健サービス（NHS）と提携してゲノム研究に2億2,236万米ドルを投資すると発表しました。この投資は、新生児のまれな遺伝性疾患の治療や発見に全ゲノムシーケンスを使用することの有効性を探ることを目的としています。

カンピロバクター感染症、A型肝炎、B型肝炎、C型肝炎、HIV、インフルエンザ、髄膜炎菌感染症などの感染症が増加していることが、市場の主な促進要因となっています。WHOによると、2022年には3,900万人がHIV感染者となります。B型肝炎財団によると、毎年約150万人が新たにB型肝炎に感染しています。アウトブレイクや伝染病の増加に伴い、これらの疾患の原因となる病原体の特定に役立つ正確で迅速なシーケンス技術に対する需要が高まっています。技術の進歩に伴い、病原体のゲノム配列決定が容易かつ迅速に行えるようになったため、ヘルスケアプロバイダーや研究者はこれらの疾患の広がりをより深く理解し、的を絞った治療法やワクチンを開発できるようになった。その結果、感染症対策と世界の健康増進の必要性から、市場は今後も成長を続けると予想されます。

COVID-19パンデミックは市場に大きな影響を与えています。ウイルスの急速な蔓延に伴い、ウイルスをより深く理解し、その変異を追跡するためのこれらの技術に対する需要が高まっています。このため、シーケンス機器、試薬、サービスに対する需要が急増しました。しかし、パンデミックはサプライチェーンを混乱させ、研究プロジェクトの遅れを引き起こしたため、市場の成長にはマイナスの影響も与えています。

同市場は、シーケンシングとデータ解析に関連する高コスト、これらの技術の精度と信頼性の限界、シーケンシングによって生成される大量のデータの管理と解釈の難しさなど、いくつかの課題に直面しています。さらに、遺伝子情報のシーケンスに関連するデータのプライバシーや倫理的意味合いに関する懸念もあります。シークエンシングの標準化と品質管理、研究者および臨床医にとってのアクセシビリティの向上、手頃な価格の実現が依然として求められています。

シーケンシング市場レポートハイライト

• 研究および診断におけるシーケンス需要の増加により、新しく改良された消耗品の開発が進んでいるため、2023年には消耗品が44.5%以上のシェアを占め、製品・サービスセグメントを支配しました。
• アプリケーション分野では、腫瘍学が2023年に最大の市場シェアを占めました。一方、メタゲノミクス、疫学＆医薬品開発はCAGR最速で成長する見込みです。
• 2023年には、ワークフロー分野ではシーケンシングが優位を占め、データ解析はCAGR最速で成長する見込みです。
• 学術研究は、知識を発展させ、科学的利益に貢献したいという願望に牽引され、より革新的な研究をもたらし、2023年に最大のシェアを獲得し、最終用途セグメントを支配しました。
• 北米は49.4%のシェアを占め、シーケンシング市場を独占しました。これは、感染症の負担が大きいこと、購買力平価が高いこと、質の高いヘルスケアに対する政府の支援があること、償還が可能であることなどの要因によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

• 市場セグメンテーションと範囲
• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 業界分析ツール
  • SWOT分析;要因別（政治・法律、経済・技術）
  • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 シーケンシング市場：製品およびサービスのビジネス分析

• シーケンシング市場：製品およびサービスの市場シェア分析
• 製品とサービス別
• プラットホーム
• 消耗品
• サービス
• ソフトウェア

第5章 シーケンシング市場：アプリケーションビジネス分析

• シーケンシング市場：アプリケーション市場シェア分析
• 用途別
• 腫瘍学
• 臨床調査
• リプロダクティブ・ヘルス
• HLAタイピング/免疫システムモニタリング
• メタゲノミクス、疫学、創薬
• アグリゲノミクスと法医学
• 消費者ゲノミクス

第6章 シーケンシング市場：ワークフロービジネス分析

• シーケンシング市場：ワークフロー市場シェア分析
• ワークフロー別
• プリシーケンス
• シーケンス
• データ分析

第7章 シーケンシング市場：最終用途ビジネス分析

• シーケンシング市場：最終用途市場シェア分析
• 最終用途別
• 学術調査
• 臨床調査
• 病院とクリニック
• 製薬およびバイオテクノロジー企業
• 他のユーザー

第8章 シーケンシング市場：地域ビジネス分析

• シーケンシング市場シェア、地域別、2023年および2030年
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 競合情勢

• 財務実績
• 参入企業
  • マーケットリーダー
• 参入企業の概要
  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • QIAGEN
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Oxford Nanopore Technologies
  • PierianDx
  • Genomatix GmbH
  • DNASTAR, Inc.
  • Perkin Elmer, Inc.
  • Eurofins GATC Biotech GmbH
  • BGI
• 戦略マッピング
  • 拡大
  • 取得
  • コラボレーション
  • 製品/サービスの開始
  • パートナーシップ
  • その他

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Global sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 4 Global sequencing market, by application, 2018 - 2030 (USD Million)
• Table 5 Global sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 6 Global sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 7 Global sequencing market, by region, 2018 - 2030 (USD Million)
• Table 8 North America sequencing market, by country, 2018 - 2030 (USD Million)
• Table 9 North America sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 10 North America sequencing market, by application, 2018 - 2030 (USD Million)
• Table 11 North America sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 12 North America sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 13 U.S. sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 14 U.S. sequencing market, by application, 2018 - 2030 (USD Million)
• Table 15 U.S. sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 16 U.S. sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 17 Canada sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 18 Canada sequencing market, by application, 2018 - 2030 (USD Million)
• Table 19 Canada sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 20 Canada sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 21 Europe sequencing market, by country, 2018 - 2030 (USD Million)
• Table 22 Europe sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 23 Europe sequencing market, by application, 2018 - 2030 (USD Million)
• Table 24 Europe sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 25 Europe sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 26 UK sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 27 UK sequencing market, by application, 2018 - 2030 (USD Million)
• Table 28 UK sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 29 UK sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 30 Germany sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 31 Germany sequencing market, by application, 2018 - 2030 (USD Million)
• Table 32 Germany sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 33 Germany sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 34 France sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 35 France sequencing market, by application, 2018 - 2030 (USD Million)
• Table 36 France sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 37 France sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 38 Italy sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 39 Italy sequencing market, by application, 2018 - 2030 (USD Million)
• Table 40 Italy sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 41 Italy sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 42 Spain sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 43 Spain sequencing market, by application, 2018 - 2030 (USD Million)
• Table 44 Spain sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 45 Spain sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 46 Denmark sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 47 Denmark sequencing market, by application, 2018 - 2030 (USD Million)
• Table 48 Denmark sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 49 Denmark sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 50 Sweden sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 51 Sweden sequencing market, by application, 2018 - 2030 (USD Million)
• Table 52 Sweden sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 53 Sweden sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 54 Norway sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 55 Norway sequencing market, by application, 2018 - 2030 (USD Million)
• Table 56 Norway sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 57 Norway sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 58 Asia Pacific sequencing market, by country, 2018 - 2030 (USD Million)
• Table 59 Asia Pacific sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 60 Asia Pacific sequencing market, by application, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 63 Japan sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 64 Japan sequencing market, by application, 2018 - 2030 (USD Million)
• Table 65 Japan sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 66 Japan sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 67 China sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 68 China sequencing market, by application, 2018 - 2030 (USD Million)
• Table 69 China sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 70 China sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 71 India sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 72 India sequencing market, by application, 2018 - 2030 (USD Million)
• Table 73 India sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 74 India sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 75 Australia sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 76 Australia sequencing market, by application, 2018 - 2030 (USD Million)
• Table 77 Australia sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 78 Australia sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 79 Thailand sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 80 Thailand sequencing market, by application, 2018 - 2030 (USD Million)
• Table 81 Thailand sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 82 Thailand sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 83 South Korea sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 84 South Korea sequencing market, by application, 2018 - 2030 (USD Million)
• Table 85 South Korea sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 86 South Korea sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 87 Latin America sequencing market, by country, 2018 - 2030 (USD Million)
• Table 88 Latin America sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 89 Latin America sequencing market, by application, 2018 - 2030 (USD Million)
• Table 90 Latin America sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 91 Latin America sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 92 Brazil sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 93 Brazil sequencing market, by application, 2018 - 2030 (USD Million)
• Table 94 Brazil sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 95 Brazil sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 96 Mexico sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 97 Mexico sequencing market, by application, 2018 - 2030 (USD Million)
• Table 98 Mexico sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 99 Mexico sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 100 Argentina sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 101 Argentina sequencing market, by application, 2018 - 2030 (USD Million)
• Table 102 Argentina sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 103 Argentina sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa sequencing market, by country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa sequencing market, by application, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 109 South Africa sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 110 South Africa sequencing market, by application, 2018 - 2030 (USD Million)
• Table 111 South Africa sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 112 South Africa sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia sequencing market, by application, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 117 UAE sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 118 UAE sequencing market, by application, 2018 - 2030 (USD Million)
• Table 119 UAE sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 120 UAE sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 121 Kuwait sequencing market, by product & services, 2018 - 2030 (USD Million)
• Table 122 Kuwait sequencing market, by application, 2018 - 2030 (USD Million)
• Table 123 Kuwait sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 124 Kuwait sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 125 Participant's overview
• Table 126 Financial performance
• Table 127 Key companies undergoing expansions
• Table 128 Key companies undergoing acquisitions
• Table 129 Key companies undergoing collaborations
• Table 130 Key companies launching new products/services
• Table 131 Key companies undertaking other strategies

List of Figures

• Fig. 1 Sequencing market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market snapshot
• Fig. 10 Segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Parent market outlook
• Fig. 13 Related/ancillary market outlook
• Fig. 14 Genomics - Industry value chain analysis
• Fig. 15 Sequencing market driver analysis
• Fig. 16 Sequencing market restraint analysis
• Fig. 17 Sequencing market: Porter's analysis
• Fig. 18 Sequencing market: Product & services outlook and key takeaways
• Fig. 19 Sequencing market: Product & services market share analysis, 2023-2030
• Fig. 20 Global sequencing by Platform market, 2018 - 2030 (USD Million)
• Fig. 21 Global sequencing by 1st Generation of sequencing device market, 2018 - 2030 (USD Million)
• Fig. 22 Global sequencing by 2nd Generation of sequencing device market, 2018 - 2030 (USD Million)
• Fig. 23 Global sequencing by 3rd Generation of sequencing device market, 2018 - 2030 (USD Million)
• Fig. 24 Global sequencing by Consumables market, 2018 - 2030 (USD Million)
• Fig. 25 Global sequencing by Kits market, 2018 - 2030 (USD Million)
• Fig. 26 Global sequencing by DNA Library Preparation market, 2018 - 2030 (USD Million)
• Fig. 27 Global sequencing by RNA Library Preparation market, 2018 - 2030 (USD Million)
• Fig. 28 Global sequencing by Target enrichment market, 2018 - 2030 (USD Million)
• Fig. 29 Global sequencing by Library quantification market, 2018 - 2030 (USD Million)
• Fig. 30 Global sequencing by Purification & quality control market, 2018 - 2030 (USD Million)
• Fig. 31 Global sequencing by Others market, 2018 - 2030 (USD Million)
• Fig. 32 Global sequencing by Reagents market, 2018 - 2030 (USD Million)
• Fig. 33 Global sequencing by Sample Prep market, 2018 - 2030 (USD Million)
• Fig. 34 Global sequencing by Library preparation and amplification market, 2018 - 2030 (USD Million)
• Fig. 35 Global sequencing by Sequencing market, 2018 - 2030 (USD Million)
• Fig. 36 Global sequencing by Accessories market, 2018 - 2030 (USD Million)
• Fig. 37 Global sequencing by Collection tubes market, 2018 - 2030 (USD Million)
• Fig. 38 Global sequencing by Plates market, 2018 - 2030 (USD Million)
• Fig. 39 Global sequencing by Others market, 2018 - 2030 (USD Million)
• Fig. 40 Global sequencing by Services market, 2018 - 2030 (USD Million)
• Fig. 41 Global sequencing by Software market, 2018 - 2030 (USD Million)
• Fig. 42 Sequencing market: Application outlook and key takeaways
• Fig. 43 Sequencing market: Application market share analysis, 2023-2030
• Fig. 44 Global sequencing by Oncology market, 2018 - 2030 (USD Million)
• Fig. 45 Global sequencing by Diagnostics and Screening market, 2018 - 2030 (USD Million)
• Fig. 46 Global sequencing by Oncology Screening market, 2018 - 2030 (USD Million)
• Fig. 47 Global sequencing by Sporadic Cancer market, 2018 - 2030 (USD Million)
• Fig. 48 Global sequencing by Inherited Cancer market, 2018 - 2030 (USD Million)
• Fig. 49 Global sequencing by Companion Diagnostics market, 2018 - 2030 (USD Million)
• Fig. 50 Global sequencing by Other Diagnostics market, 2018 - 2030 (USD Million)
• Fig. 51 Global sequencing by Research Studies market, 2018 - 2030 (USD Million)
• Fig. 52 Global sequencing by Clinical Investigation market, 2018 - 2030 (USD Million)
• Fig. 53 Global sequencing by Infectious Diseases market, 2018 - 2030 (USD Million)
• Fig. 54 Global sequencing by Inherited Diseases market, 2018 - 2030 (USD Million)
• Fig. 55 Global sequencing by Idiopathic Diseases market, 2018 - 2030 (USD Million)
• Fig. 56 Global sequencing by Non-Communicable/Other Diseases market, 2018 - 2030 (USD Million)
• Fig. 57 Global sequencing by Reproductive Health market, 2018 - 2030 (USD Million)
• Fig. 58 Global sequencing by NIPT market, 2018 - 2030 (USD Million)
• Fig. 59 Global sequencing by Aneuploidy market, 2018 - 2030 (USD Million)
• Fig. 60 Global sequencing by Microdeletions market, 2018 - 2030 (USD Million)
• Fig. 61 Global sequencing by PGT market, 2018 - 2030 (USD Million)
• Fig. 62 Global sequencing by Newborn Genetic Screening market, 2018 - 2030 (USD Million)
• Fig. 63 Global sequencing by Single Gene Analysis market, 2018 - 2030 (USD Million)
• Fig. 64 Global sequencing by HLA Typing/Immune System Monitoring market, 2018 - 2030 (USD Million)
• Fig. 65 Global sequencing by Metagenomics, Epidemiology & Drug Development market, 2018 - 2030 (USD Million)
• Fig. 66 Global sequencing by Agrigenomics & Forensics market, 2018 - 2030 (USD Million)
• Fig. 67 Global sequencing by Consumer Genomics market, 2018 - 2030 (USD Million)
• Fig. 68 Sequencing market: Workflow outlook and key takeaways
• Fig. 69 Sequencing market: Workflow market share analysis, 2023-2030
• Fig. 70 Global sequencing by Pre-Sequencing market, 2018 - 2030 (USD Million)
• Fig. 71 Global sequencing by Sequencing market, 2018 - 2030 (USD Million)
• Fig. 72 Global sequencing by Data Analysis market, 2018 - 2030 (USD Million)
• Fig. 73 Sequencing market: End-use outlook and key takeaways
• Fig. 74 Sequencing market: End-use market share analysis, 2023-2030
• Fig. 75 Global sequencing by Academic Research market, 2018 - 2030 (USD Million)
• Fig. 76 Global sequencing by Clinical Research market, 2018 - 2030 (USD Million)
• Fig. 77 Global sequencing by Hospitals & Clinics market, 2018 - 2030 (USD Million)
• Fig. 78 Global sequencing by Pharma & Biotech Entities market, 2018 - 2030 (USD Million)
• Fig. 79 Global sequencing by Other users market, 2018 - 2030 (USD Million)
• Fig. 80 Regional marketplace: Key takeaways
• Fig. 81 Regional marketplace: Key takeaways
• Fig. 82 North America sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 U.S. key country dynamics
• Fig. 84 U.S. sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 85 Canada key country dynamics
• Fig. 86 Canada sequencing market, 2018 - 2030 (USD Million)
• Fig. 87 Europe sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 UK key country dynamics
• Fig. 89 UK sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 Germany key country dynamics
• Fig. 91 Germany sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 France key country dynamics
• Fig. 93 France sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 Italy key country dynamics
• Fig. 95 Italy sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 96 Spain key country dynamics
• Fig. 97 Spain sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 98 Denmark key country dynamics
• Fig. 99 Denmark sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 100 Sweden key country dynamics
• Fig. 101 Sweden sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 102 Norway key country dynamics
• Fig. 103 Norway sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 104 Asia-Pacific sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 105 Japan key country dynamics
• Fig. 106 Japan sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 107 China key country dynamics
• Fig. 108 China sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 109 India key country dynamics
• Fig. 110 India sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 111 Australia key country dynamics
• Fig. 112 Australia sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 113 Thailand key country dynamics
• Fig. 114 Thailand sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 115 South Korea key country dynamics
• Fig. 116 South Korea sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 117 Latin America sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 118 Brazil key country dynamics
• Fig. 119 Brazil sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 120 Mexico key country dynamics
• Fig. 121 Mexico sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 122 Argentina key country dynamics
• Fig. 123 Argentina sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 124 MEA sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 125 South Africa key country dynamics
• Fig. 126 South Africa sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 127 Saudi Arabia key country dynamics
• Fig. 128 Saudi Arabia sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 129 UAE key country dynamics
• Fig. 130 UAE sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 131 Kuwait key country dynamics
• Fig. 132 Kuwait sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 133 Key company categorization
• Fig. 134 Company market positioning
• Fig. 135 Market participant categorization
• Fig. 136 Strategy framework

Sequencing Market Growth & Trends:

The global sequencing market size is anticipated to reach USD 62.48 billion by 2030, growing at a CAGR of 22.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing investments by governments and private organizations in genomic research and development and the increasing demand for personalized medicine and precision treatments have led to a rise in the adoption of these technologies, which are expected to boost the market further. For instance, in December 2022, the UK government announced a USD 222.36 million investment in genomics research in partnership with the National Health Service (NHS). This investment aimed to explore the effectiveness of using whole-genome sequencing to treat and find rare genetic diseases in newborn babies.

The rising number of infectious diseases such as Campylobacter infection, Hepatitis A, B, C, HIV, Influenza (Flu), and Meningococcal disease has been a major driver of the market. According to WHO, in 2022, 39 million people are living with HIV. As per the Hepatitis B Foundation, approximately 1.5 million people are newly infected due to hepatitis B each year. As the number of outbreaks and epidemics increases, there is a growing demand for accurate and rapid sequencing technologies that can help identify the pathogens responsible for these diseases. With the advancement of technologies, it has become easier and faster to sequence the genomes of pathogens, enabling healthcare providers and researchers to understand the spread of these diseases better and develop targeted treatments and vaccines. As a result, the market is expected to continue to grow in the coming years, driven by the need to combat infectious diseases and improve global health.

The COVID-19 pandemic has had a significant impact on the market. With the rapid spread of the virus, there has been an increased demand for these technologies to understand the virus better and track its mutations. This has led to a surge in demand for sequencing instruments, reagents, and services. However, the pandemic has also disrupted supply chains and caused delays in research projects, which has had a negative impact on the market growth.

The market faces several challenges, including high costs associated with sequencing and data analysis, limited accuracy and reliability of these technologies, and difficulties in managing and interpreting large amounts of data generated by sequencing. In addition, there are concerns regarding data privacy and ethical implications related to sequencing genetic information. There is still a need for standardization and quality control in sequencing, improved accessibility, and affordability for researchers and clinicians.

Sequencing Market Report Highlights:

• Consumables dominated the product & service segment with more than 44.5% share in 2023 owing to the increasing demand for sequencing in research and diagnostics, which has resulted in the development of new and improved consumables
• In application segment, oncology held the largest market share in 2023. On the other hand, metagenomics, epidemiology & drug development is expected to grow at the fastest CAGR
• In 2023, sequencing dominated the workflow segment, and data analysis is expected to at the fastest CAGR
• Academic research dominated the end-use segment with largest share in 2023 driven by a desire to advance knowledge and contribute to scientific interests, resulting in more innovative research
• North America dominated the sequencing market with a share of 49.4% owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product & Services
  • 1.2.2. Application
  • 1.2.3. Workflow
  • 1.2.4. End-use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Increasing Cases of Cancer
    • 3.3.1.2. Technological advances in next-generation sequencing technologies
    • 3.3.1.3. High investment in research and development
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. Lack of Skilled Professionals
    • 3.3.2.2. Legal and Ethical Issues
• 3.4. Industry Analysis Tools
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.4.2. Porter's Five Forces Analysis
  • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Sequencing market: Product & Services Business Analysis

• 4.1. Sequencing market: Product & Services Market Share Analysis
• 4.2. Sequencing market Estimates & Forecast, By Product & Services (USD Million)
• 4.3. Platform
  • 4.3.1. Global Platform Market, 2018 - 2030 (USD Million)
  • 4.3.2. 1st Generation of Sequencing Device
    • 4.3.2.1. Global 1st Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
  • 4.3.3. 2nd Generation of Sequencing Device
    • 4.3.3.1. Global 2nd Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
  • 4.3.4. 3rd Generation of Sequencing Device
    • 4.3.4.1. Global 3rd Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
• 4.4. Consumables
  • 4.4.1. Global Consumables Market, 2018 - 2030 (USD Million)
  • 4.4.2. Kits
    • 4.4.2.1. Global Kits Market, 2018 - 2030 (USD Million)
    • 4.4.2.2. DNA Library Preparation
    • 4.4.2.2.1. Global DNA Library Preparation Market, 2018 - 2030 (USD Million)
    • 4.4.2.3. RNA Library Preparation
    • 4.4.2.3.1. Global RNA Library Preparation Market, 2018 - 2030 (USD Million)
    • 4.4.2.4. Target enrichment
    • 4.4.2.4.1. Global Target enrichment Market, 2018 - 2030 (USD Million)
    • 4.4.2.5. Library quantification
    • 4.4.2.5.1. Global Library quantification Market, 2018 - 2030 (USD Million)
    • 4.4.2.6. Purification & quality control
    • 4.4.2.6.1. Global Purification & quality control Market, 2018 - 2030 (USD Million)
    • 4.4.2.7. Others
    • 4.4.2.7.1. Global Others Market, 2018 - 2030 (USD Million)
  • 4.4.3. Reagents
    • 4.4.3.1. Global Reagents Market, 2018 - 2030 (USD Million)
    • 4.4.3.2. Sample Prep
    • 4.4.3.2.1. Global Sample Prep Market, 2018 - 2030 (USD Million)
    • 4.4.3.3. Library preparation and amplification
    • 4.4.3.3.1. Global Library preparation and amplification Market, 2018 - 2030 (USD Million)
    • 4.4.3.4. Sequencing
    • 4.4.3.4.1. Global Sequencing Market, 2018 - 2030 (USD Million)
  • 4.4.4. Accessories
    • 4.4.4.1. Global Accessories Market, 2018 - 2030 (USD Million)
    • 4.4.4.2. Collection tubes
    • 4.4.4.2.1. Global Collection tubes Market, 2018 - 2030 (USD Million)
    • 4.4.4.3. Plates
    • 4.4.4.3.1. Global Plates Market, 2018 - 2030 (USD Million)
    • 4.4.4.4. Others
    • 4.4.4.4.1. Global Others Market, 2018 - 2030 (USD Million)
• 4.5. Services
  • 4.5.1. Global Services Market, 2018 - 2030 (USD Million)
• 4.6. Software
  • 4.6.1. Global Software Market, 2018 - 2030 (USD Million)

Chapter 5. Sequencing Market: Application Business Analysis

• 5.1. Sequencing Market: Application Market Share Analysis
• 5.2. Sequencing Market Estimates & Forecast, By Application (USD Million)
• 5.3. Oncology
  • 5.3.1. Global Oncology Market, 2018 - 2030 (USD Million)
  • 5.3.2. Diagnostics and Screening
    • 5.3.2.1. Global Diagnostics and Screening Market, 2018 - 2030 (USD Million)
  • 5.3.3. Oncology Screening
    • 5.3.3.1. Global Oncology Screening Market, 2018 - 2030 (USD Million)
    • 5.3.3.1.1. Sporadic Cancer
    • 5.3.3.1.1.1. Global Sporadic Cancer Market, 2018 - 2030 (USD Million)
    • 5.3.3.1.2. Inherited Cancer
    • 5.3.3.1.2.1. Global Inherited Cancer Market, 2018 - 2030 (USD Million)
  • 5.3.4. Companion Diagnostics
    • 5.3.4.1. Global Companion Diagnostics Market, 2018 - 2030 (USD Million)
  • 5.3.5. Other Diagnostics
    • 5.3.5.1. Global Other Diagnostics Market, 2018 - 2030 (USD Million)
  • 5.3.6. Research Studies
    • 5.3.6.1. Global Research Studies Market, 2018 - 2030 (USD Million)
• 5.4. Clinical Investigation
  • 5.4.1. Global Clinical Investigation Market, 2018 - 2030 (USD Million)
  • 5.4.2. Infectious Diseases
    • 5.4.2.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 5.4.3. Inherited Diseases
    • 5.4.3.1. Global Inherited Diseases Market, 2018 - 2030 (USD Million)
  • 5.4.4. Idiopathic Diseases
    • 5.4.4.1. Global Idiopathic Diseases Market, 2018 - 2030 (USD Million)
  • 5.4.5. Non-Communicable/Other Diseases
    • 5.4.5.1. Global Non-Communicable/Other Diseases Market, 2018 - 2030 (USD Million)
• 5.5. Reproductive Health
  • 5.5.1. Global Reproductive Health Market, 2018 - 2030 (USD Million)
  • 5.5.2. NIPT
    • 5.5.2.1. Global NIPT Market, 2018 - 2030 (USD Million)
    • 5.5.2.2. Aneuploidy
    • 5.5.2.2.1. Global Aneuploidy Market, 2018 - 2030 (USD Million)
    • 5.5.2.3. Microdeletions
    • 5.5.2.3.1. Global Microdeletions Market, 2018 - 2030 (USD Million)
  • 5.5.3. PGT
    • 5.5.3.1. Global PGT Market, 2018 - 2030 (USD Million)
  • 5.5.4. Newborn Genetic Screening
    • 5.5.4.1. Global Newborn Genetic Screening Market, 2018 - 2030 (USD Million)
  • 5.5.5. Single Gene Analysis
    • 5.5.5.1. Global Single Gene Analysis Market, 2018 - 2030 (USD Million)
• 5.6. HLA Typing/Immune System Monitoring
  • 5.6.1. Global HLA Typing/Immune System Monitoring Market, 2018 - 2030 (USD Million)
• 5.7. Metagenomics, Epidemiology & Drug Development
  • 5.7.1. Global Metagenomics, Epidemiology & Drug Development Market, 2018 - 2030 (USD Million)
• 5.8. Agrigenomics & Forensics
  • 5.8.1. Global Agrigenomics & Forensics Market, 2018 - 2030 (USD Million)
• 5.9. Consumer Genomics
  • 5.9.1. Global Consumer Genomics Market, 2018 - 2030 (USD Million)

Chapter 6. Sequencing Market: Workflow Business Analysis

• 6.1. Sequencing Market: Workflow Market Share Analysis
• 6.2. Sequencing Market Estimates & Forecast, By Workflow (USD Million)
• 6.3. Pre-Sequencing
  • 6.3.1. Global Pre-sequencing Market, 2018 - 2030 (USD Million)
• 6.4. Sequencing
  • 6.4.1. Global Sequencing Market, 2018 - 2030 (USD Million)
• 6.5. Data Analysis
  • 6.5.1. Global Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Sequencing Market: End-use Business Analysis

• 7.1. Sequencing market: End-use Market Share Analysis
• 7.2. Sequencing market Estimates & Forecast, By End-use (USD Million)
• 7.3. Academic Research
  • 7.3.1. Global Academic Research Market, 2018 - 2030 (USD Million)
• 7.4. Clinical Research
  • 7.4.1. Global Clinical Research Market, 2018 - 2030 (USD Million)
• 7.5. Hospitals & Clinics
  • 7.5.1. Global Hospitals & Clinics Market, 2018 - 2030 (USD Million)
• 7.6. Pharma & Biotech Entities
  • 7.6.1. Global Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
• 7.7. Other Users
  • 7.7.1. Global Other Users Market, 2018 - 2030 (USD Million)

Chapter 8. Sequencing Market: Regional Business Analysis

• 8.1. Sequencing Market Share, By Region, 2023 & 2030
• 8.2. North America
  • 8.2.1. North America Sequencing market, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Competitive Scenario
    • 8.2.2.3. Target Disease Prevalence
    • 8.2.2.4. Regulatory Framework
    • 8.2.2.5. U.S. Sequencing market, 2018 - 2030 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Competitive Scenario
    • 8.2.3.3. Target Disease Prevalence
    • 8.2.3.4. Regulatory Framework
    • 8.2.3.5. Canada Sequencing market, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Target Disease Prevalence
    • 8.3.2.4. Regulatory Framework
    • 8.3.2.5. UK Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Target Disease Prevalence
    • 8.3.3.4. Regulatory Framework
    • 8.3.3.5. Germany Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Target Disease Prevalence
    • 8.3.4.4. Regulatory Framework
    • 8.3.4.5. France Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Competitive Scenario
    • 8.3.5.3. Target Disease Prevalence
    • 8.3.5.4. Regulatory Framework
    • 8.3.5.5. Italy Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Competitive Scenario
    • 8.3.6.3. Target Disease Prevalence
    • 8.3.6.4. Regulatory Framework
    • 8.3.6.5. Spain Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.7. Denmark
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Competitive Scenario
    • 8.3.7.3. Target Disease Prevalence
    • 8.3.7.4. Regulatory Framework
    • 8.3.7.5. Denmark Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.8. Sweden
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Competitive Scenario
    • 8.3.8.3. Target Disease Prevalence
    • 8.3.8.4. Regulatory Framework
    • 8.3.8.5. Sweden Sequencing market, 2018 - 2030 (USD Million)
  • 8.3.9. Norway
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Competitive Scenario
    • 8.3.9.3. Target Disease Prevalence
    • 8.3.9.4. Regulatory Framework
    • 8.3.9.5. Norway Sequencing market, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific Sequencing market, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Target Disease Prevalence
    • 8.4.2.4. Regulatory Framework
    • 8.4.2.5. Japan Sequencing market, 2018 - 2030 (USD Million)
  • 8.4.3. China
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Target Disease Prevalence
    • 8.4.3.4. Regulatory Framework
    • 8.4.3.5. China Sequencing market, 2018 - 2030 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Target Disease Prevalence
    • 8.4.4.4. Regulatory Framework
    • 8.4.4.5. India Sequencing market, 2018 - 2030 (USD Million)
  • 8.4.5. Australia
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Target Disease Prevalence
    • 8.4.5.4. Regulatory Framework
    • 8.4.5.5. Australia Sequencing market, 2018 - 2030 (USD Million)
  • 8.4.6. Thailand
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Target Disease Prevalence
    • 8.4.6.4. Regulatory Framework
    • 8.4.6.5. Thailand Sequencing market, 2018 - 2030 (USD Million)
  • 8.4.7. South Korea
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Target Disease Prevalence
    • 8.4.7.4. Regulatory Framework
    • 8.4.7.5. South Korea Sequencing market, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America Sequencing market, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Target Disease Prevalence
    • 8.5.2.4. Regulatory Framework
    • 8.5.2.5. Brazil Sequencing market, 2018 - 2030 (USD Million)
  • 8.5.3. Mexico
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Target Disease Prevalence
    • 8.5.3.4. Regulatory Framework
    • 8.5.3.5. Mexico Sequencing market, 2018 - 2030 (USD Million)
  • 8.5.4. Argentina
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Target Disease Prevalence
    • 8.5.4.4. Regulatory Framework
    • 8.5.4.5. Argentina Sequencing market, 2018 - 2030 (USD Million)
• 8.6. MEA
  • 8.6.1. MEA Sequencing market, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Target Disease Prevalence
    • 8.6.2.4. Regulatory Framework
    • 8.6.2.5. South Africa Sequencing market, 2018 - 2030 (USD Million)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Target Disease Prevalence
    • 8.6.3.4. Regulatory Framework
    • 8.6.3.5. Saudi Arabia Sequencing market, 2018 - 2030 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Target Disease Prevalence
    • 8.6.4.4. Regulatory Framework
    • 8.6.4.5. UAE Sequencing market, 2018 - 2030 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Target Disease Prevalence
    • 8.6.5.4. Regulatory Framework
    • 8.6.5.5. Kuwait Sequencing market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Financial Performance
• 9.2. Participant Categorization
  • 9.2.1. Market Leaders
    • 9.2.1.1. Market share analysis, 2023
• 9.3. Participant's Overview
  • 9.3.1. Illumina, Inc.
    • 9.3.1.1. Overview
    • 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.1.3. Technology Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. F. Hoffman-La Roche Ltd.
    • 9.3.2.1. Overview
    • 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.2.3. Technology Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. QIAGEN
    • 9.3.3.1. Overview
    • 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.3.3. Technology Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Thermo Fisher Scientific, Inc.
    • 9.3.4.1. Overview
    • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.4.3. Technology Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Bio-Rad Laboratories, Inc.
    • 9.3.5.1. Overview
    • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.5.3. Technology Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Oxford Nanopore Technologies
    • 9.3.6.1. Overview
    • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.6.3. Technology Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. PierianDx
    • 9.3.7.1. Overview
    • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.7.3. Technology Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Genomatix GmbH
    • 9.3.8.1. Overview
    • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.8.3. Technology Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. DNASTAR, Inc.
    • 9.3.9.1. Overview
    • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.9.3. Technology Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Perkin Elmer, Inc.
    • 9.3.10.1. Overview
    • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.10.3. Technology Benchmarking
    • 9.3.10.4. Strategic Initiatives
  • 9.3.11. Eurofins GATC Biotech GmbH
    • 9.3.11.1. Overview
    • 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.11.3. Technology Benchmarking
    • 9.3.11.4. Strategic Initiatives
  • 9.3.12. BGI
    • 9.3.12.1. Overview
    • 9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.3.12.3. Technology Benchmarking
    • 9.3.12.4. Strategic Initiatives
• 9.4. Strategy Mapping
  • 9.4.1. Expansion
  • 9.4.2. Acquisition
  • 9.4.3. Collaborations
  • 9.4.4. Product/service launch
  • 9.4.5. Partnerships
  • 9.4.6. Others